Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?
Open Access
- 19 December 2019
- journal article
- review article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 31 (2) , 375-395
Abstract
Expressed on virtually all prostate cancers and their metastases, the transmembrane protein prostate-specific membrane antigen (PSMA) provides a valuable target for the imaging of prostate cancer. Not only does PSMA provide a target for non-invasive diagnostic imaging e.g., PSMA-positron emission tomography (PSMA-PET), it can also be used to guide surgical resections of PSMA-positive lesions. The latter characteristic has led to the development of a plethora of PSMA-targeted tracers, i.e., radiolabeled, fluorescent, or hybrid tracers. With image-guided surgery applications in mind, this review discusses these compounds based on clinical need. Here, the focus is on the chemical aspects (e.g., imaging label, spacer moiety, and targeting vector) and their impact on in vitro and in vivo tracer characteristics (e.g., affinity, tumor uptake and clearance pattern).Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (TTW 16141)
This publication has 131 references indexed in Scilit:
- Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate‐Specific Membrane AntigenAngewandte Chemie International Edition, 2011
- Approaches using molecular imaging technology — use of PET in clinical microdose studiesAdvanced Drug Delivery Reviews, 2011
- Steps in prostate cancer progression that lead to bone metastasisInternational Journal of Cancer, 2011
- Radiation exposure to nuclear medicine personnel handling positron emitters from Ge-68/Ga-68 generatorIndian Journal of Nuclear Medicine, 2011
- Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studiesBioorganic & Medicinal Chemistry Letters, 2010
- A low molecular weight PSMA-based fluorescent imaging agent for cancerBiochemical and Biophysical Research Communications, 2009
- Simplified syntheses of complex multifunctional nanomaterialsChemical Communications, 2008
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)Journal of Medicinal Chemistry, 2008
- Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using 111In-J591: Lesion Detectability and Dosimetric Projections for 90Y RadioimmunotherapyJournal of Nuclear Medicine, 2008
- Imaging of Lymph Flow in Breast Cancer Patients after Microdose Administration of a Near-Infrared Fluorophore: Feasibility StudyRadiology, 2008